Zimmer Holdings to Present at Thomas Weisel Partners ...( WARSAW Ind. Aug. 27 /- Zimmer Hol...),Health
Navigation Links
Zimmer Holdings to Present at Thomas Weisel Partners Conference
Date:8/27/2008
WARSAW, Ind., Aug. 27 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE ZMH; SWX: ZMH), a leader in the orthopaedics industry, announced today it will be participating in the Thomas Weisel Partners Healthcare Conference 2008 in Boston, Massachusetts, on September 3, 2008, at 8:35 a.m. Eastern Time.
A live webcast of the presentation can be accessed via Zimmer's Investor Relations website at http://investor.zimmer.com . The webcast will be archived for replay following the conference.
About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related orthopaedic surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2007 sales were approximately $3.9 billion. The Company is supported by the efforts of approximately 8,500 employees worldwide.
Visit Zimmer on the worldwide web at http://www.zimmer.com
'/>"/>
| SOURCE Zimmer Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Zimmer Holdings Issues Clarification Regarding NexGen Knee System
2. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2008 Results
3. Zimmer Holdings to Partner with AmeriCares for Global Product Donation Program
4. Zimmer Holdings Names Mark C. Throdahl Group President, Global Businesses
5. Zimmer Holdings to Present at Deutsche Bank 33rd Annual Health Care Conference
6. Zimmer Holdings, Inc. Reports First Quarter Financial Results
7. Zimmer Holdings to Present at Morgan Stanley Healthcare Unplugged Conference
8. Zimmer Announces New Compliance Model
9. Zimmer Announces Actions Affecting its Ohio-based Orthopaedic Surgical Products Operation
10. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2008 Results
11. Zimmer Holdings to Present at Upcoming Investor Conferences
Post Your Comments:
(Date:11/24/2009)...USNewswire/--Parties,familydinners,andothergatheri...tthemerrimentcanchangetomiseryiffoodmakesyouorothe.../prnh/20090824/FDALOGO ) ,, Typicalsymptomsoffo...toms,whichcanstartanywherefromhourstodaysaftercont...sisthatpracticingfourbasicfoodsafetymeasurescanhel...
(Date:11/24/2009)...USNewswire/--IPROhasachieveditsthirdconsecutiveISO...dardfocusedonfulfillingcustomerrequirements,enhanc...nessperformance.CertificationtoISO9001:2008bySGSIn...ManagementSystem(QMS)haspassedarigorousexternalaud...ndAlbany,NewYorkaswellasatitsaffiliateLogiqual,LLC...
(Date:11/24/2009)...--Mostpeoplelookforwardtokickingofftheholidayseaso...andfamily.TheMacombCountyHealthDepartmentremindsyo...elingandbeinginlargegroupsareeasywaystospreadfluge... VACCINATION ,, Thefirstandmostimportantstepis...ainsttheH1N1strainoftheflu.TheMacombCountyHealthDe...
(Date:11/24/2009)...ire/--Nextmonth,UnitedHealthcarewilloffertwofreeMe...icanseniorsunderstandthebasicsofMedicare.Following...74;Goldclass,aLatin-infusedfitnessprogramthatblend... ,, UnitedHealthcarewilloffertheseseminarsinSpa...rningabouttheirhealthcareoptions. Thereareapproxi...
(Date:11/24/2009)...l/--CenteneCorporation(NYSE: CNC )todayannouncedth...neasoneoftwoCoordinatedCareOrganizationstoparticip...sippiCAN),acoordinatedcareprogramforMississippiMed...toexecuteacontractinwhichthecompanywillserveeligib...agnolia). ,, BasedinJackson,Miss.,Magnoliawillw...
Breaking Medicine News(10 mins):Health News:FDA Consumer Health Information: Food Safety Tips for Healthy Holidays 2Health News:IPRO Earns Third Consecutive Quality Management Certification 2Health News:Tips To Enjoy a Flu-Free Holiday Season 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2[0] FDA Consumer Health Information: Food Safety Tips for Healthy Holidays[0] IPRO Earns Third Consecutive Quality Management Certification[2] Tips To Enjoy a Flu-Free Holiday Season[1] UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program[0] Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi
... Chicago, Ill.--The interaction of sex, age and e...val in metastatic colorectal cancer (MCRC) patient... Southern California (USC) and USC/Norris Comprehe...t gender also plays an important role in overall s...
... The passing of time makes ovaries lose their abi...rmones which regulate the menstrual cycle. In this...sical and psychical changes such as hot flushes, s...ain, the average age for the cessation of the mens...
...ETROIT, May 29 Caraco Pharmaceutical,Laboratories...he fourth,quarter and the year ended March 31, 200...ion, respectively, as compared to $32.7 million an...08,respectively, as compared to net income of $9.5...
...merifit Brands Educates Consumers about Urinary He... realize its,prevalence, urinary tract infections ...n in the body, and account for more than 8 million...lifetime.(2),However, many women do not realize th...
...esearch adds to what is known about relationship b... The risk of developing,type 2 diabetes in women ...ow cardiorespiratory fitness or higher Body Mass I... American,College of Sports Medicine (ACSM). An in...
...air of studies features biomechanical analysis of ...flip-flops as their primary footwear option during...and a change in their stride, according to,researc...s study began with the observation,that most peopl...
Other Medicine News:Health News:USC study finds sex, age and ethnicity assciated with colorectal cancer survival 2Health News:Post-menopausal therapy to improve women's quality of life 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 4Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 5Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 6Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 7Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 8Health News:AZO Answers the Burning Question: What's Up Down There? 2Health News:AZO Answers the Burning Question: What's Up Down There? 3Health News:AZO Answers the Burning Question: What's Up Down There? 4Health News:Studies Define Type 2 Diabetes Risk Factors in Women, Adolescents 2Health News:Studies Define Type 2 Diabetes Risk Factors in Women, Adolescents 3Health News:Studies Define Type 2 Diabetes Risk Factors in Women, Adolescents 4Health News:Flip-Flops, Heels Examined for Performance, Impact 2Health News:Flip-Flops, Heels Examined for Performance, Impact 3USC study finds sex, age and ethnicity assciated with colorectal cancer survivalPost-menopausal therapy to improve women's quality of lifeCaraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008AZO Answers the Burning Question: What's Up Down There?Studies Define Type 2 Diabetes Risk Factors in Women, AdolescentsFlip-Flops, Heels Examined for Performance, Impact
(Date:11/24/2009)...TSBURGH,Nov.24/PRNewswire/-- ,, WHAT:RomHoubens...winganautoaccident,wasactuallyfullyconsciousandawa...icasegment.TheDynaVoxEyeMaxwasfeaturedinthesegment...conditionscanunlockcommunication. ,, WHEN:GoodM...at www.dynavoxtech.com ,, WHO:RomHoubens...
(Date:11/24/2009)...DCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewswire/-- Ei...dDrugAdministration(FDA)hasacceptedforreviewEisai,...74;(donepezilHClextendedrelease)tabletsforthetreat...ewhigherdoseformulationcontains23mgofdonepezilHCli...ystemthatallowsforgradualreleaseofthedrug.TheNDAis...
(Date:11/24/2009)...EIGH,N.C.,Nov.24/PRNewswire/--PharmaceuticalInstit...forthepharmaceuticalandbiotechindustry,todayannoun...ace .Thenew HospitalMarketplace e-courseisthenewes...M) series,acomprehensiveseriesofe-coursesdesignedt...etsknowledgeforcommercialprofessionals. ,, Then...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2Brain Training Keeps Older Drivers Safe Behind the Wheel 57315 1Brain Training Keeps Older Drivers Safe Behind the Wheel 57315 2Brain Training Keeps Older Drivers Safe Behind the Wheel 57315 3BioSpecifics Technologies Corp Stock Trading Halted Today 14076 1GENova and TheraGlass in advanced negotiations 57312 1GENova and TheraGlass in advanced negotiations 57312 2GENova and TheraGlass in advanced negotiations 57312 3...--May 2, 2007 - Acorda Therapeutics, Inc.(R),(Nasd...ical trial,of Fampridine-SR in people with multipl...ogy meeting. Andrew Goodman, M.D.,Director of the...chester, presented top-line results on walking abi...ubject global impressions.,Dr. Goodman also presen...
...May 02, 2007 /PRNewswire-FirstCall/ --,Genelabs Te...on was,made today at the 20th International Confer...ngs, California, on a,non-nucleoside hepatitis C v...labs. , The oral presentation was given by Christo...istry at Genelabs, entitled,"GL59728: A Potent All...
Other Medicine Technology:Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 2Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 4Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 5Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 6Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 7Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 2Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |